These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 27629998)

  • 1. Myoclonus and seizures in progressive myoclonus epilepsies: pharmacology and therapeutic trials.
    Michelucci R; Pasini E; Riguzzi P; Andermann E; Kälviäinen R; Genton P
    Epileptic Disord; 2016 Sep; 18(S2):145-153. PubMed ID: 27629998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Pharmacological Treatment of Progressive Myoclonus Epilepsies.
    Ferlazzo E; Trenite DK; Haan GJ; Felix Nitschke F; Ahonen S; Gasparini S; Minassian BA
    Curr Pharm Des; 2017; 23(37):5662-5666. PubMed ID: 28799509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Debate: Does genetic information in humans help us treat patients? PRO--genetic information in humans helps us treat patients. CON--genetic information does not help at all.
    Delgado-Escueta AV; Bourgeois BF
    Epilepsia; 2008 Dec; 49 Suppl 9():13-24. PubMed ID: 19087113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perampanel Improves Cortical Myoclonus and Disability in Progressive Myoclonic Epilepsies: A Case Series and a Systematic Review of the Literature.
    Assenza G; Nocerino C; Tombini M; Di Gennaro G; D'Aniello A; Verrotti A; Marrelli A; Ricci L; Lanzone J; Di Lazzaro V; Bilo L; Coppola A
    Front Neurol; 2021; 12():630366. PubMed ID: 33841303
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N; Besag F; Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of the efficacy of perampanel as treatment for myoclonic seizures and symptomatic myoclonus.
    Mir A; Alghamdi A; Alotaibi W; Samreen D; Alotaibi M; Albaradie R; Bashir S
    Epileptic Disord; 2022 Aug; 24(4):633-646. PubMed ID: 35770766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical picture of EPM1-Unverricht-Lundborg disease.
    Kälviäinen R; Khyuppenen J; Koskenkorva P; Eriksson K; Vanninen R; Mervaala E
    Epilepsia; 2008 Apr; 49(4):549-56. PubMed ID: 18325013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease.
    Genton P; Gelisse P; Crespel A
    Epilepsia; 2006 Dec; 47(12):2083-5. PubMed ID: 17201707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options in juvenile myoclonic epilepsy.
    Mantoan L; Walker M
    Curr Treat Options Neurol; 2011 Aug; 13(4):355-70. PubMed ID: 21494841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of epilepsy in MERRF syndrome.
    Finsterer J; Zarrouk-Mahjoub S
    Seizure; 2017 Aug; 50():166-170. PubMed ID: 28686997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation and progressive myoclonus epilepsies: from basic science to therapeutic opportunities.
    Sanz P; Serratosa JM
    Expert Rev Mol Med; 2020 Sep; 22():e4. PubMed ID: 32938505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy.
    Orsini A; Valetto A; Bertini V; Esposito M; Carli N; Minassian BA; Bonuccelli A; Peroni D; Michelucci R; Striano P
    Seizure; 2019 Oct; 71():247-257. PubMed ID: 31476531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pediatric epilepsy: expert opinion, 2005.
    Wheless JW; Clarke DF; Carpenter D
    J Child Neurol; 2005 Dec; 20 Suppl 1():S1-56; quiz S59-60. PubMed ID: 16615562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating myoclonic epilepsy in children: state-of-the-art.
    Striano P; Belcastro V
    Expert Opin Pharmacother; 2013 Jul; 14(10):1355-61. PubMed ID: 23668690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful treatment of epilepsy and circadian rhythm disturbance with levetiracetam in a patient with dentatorubral-pallidoluysian atrophy (DRPLA)].
    Hamada S; Shimakawa S; Satomura S; Naito E; Hashimoto T
    No To Hattatsu; 2014 Nov; 46(6):439-42. PubMed ID: 25558587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive Myoclonus Epilepsies.
    Kälviäinen R
    Semin Neurol; 2015 Jun; 35(3):293-9. PubMed ID: 26060909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive myoclonic epilepsies: it takes a village to make a diagnosis.
    Knupp K; Wirrell E
    Neurology; 2014 Feb; 82(5):378-9. PubMed ID: 24384640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular genetic bases of the progressive myoclonus epilepsies.
    Serratosa JM; Gardiner RM; Lehesjoki AE; Pennacchio LA; Myers RM
    Adv Neurol; 1999; 79():383-98. PubMed ID: 10514828
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.